Abstract
Currently, humanity is suffering from a highly contagious and infectious novel coronavirus disease. Due to the unavailability of any specifically approved therapy to eradicate this pathogenic virus, day by day, it is claiming more and more lives of humans. Observing the current scenario, human civilization seems to be in dangerous situation, and the development of a potential vaccine against this invisible enemy may take some more time. It was observed that the individual immune system plays an important role in the fight against the novel coronavirus. Additionally, the innate immune system of the host acts as the first line of defense against invading pathogenic viruses. The host innate immune cells can detect and detoxify the evading viruses. Thus, boosting the innate immune response via targeting activator or inhibitory immune check points pathways for enhancing T-cell immune response may potentially help the patients to fight against this deadly virus. The aim of this editorial is to discuss in brief about the pathogenesis of COVID-19, the role of innate immunity and autophagy during viral clearance.
Keywords: COVID-19, convalescent plasma therapy, innate immunity, novel coronavirus, SARS-CoV-2, pathogenesis of COVID.
Coronaviruses
Title:Boosting Innate Immunity During SARS-CoV-2 Clearance
Volume: 2 Issue: 8
Author(s): Abhishesh Kumar Mehata*, Deepa Dehari, Anuj Kumar Mehta and Alim Miya
Affiliation:
- Department of Pharmaceutical Engineering and Technology, Indian Institute of Technology (BHU), Varanasi– 221005,India
Keywords: COVID-19, convalescent plasma therapy, innate immunity, novel coronavirus, SARS-CoV-2, pathogenesis of COVID.
Abstract: Currently, humanity is suffering from a highly contagious and infectious novel coronavirus disease. Due to the unavailability of any specifically approved therapy to eradicate this pathogenic virus, day by day, it is claiming more and more lives of humans. Observing the current scenario, human civilization seems to be in dangerous situation, and the development of a potential vaccine against this invisible enemy may take some more time. It was observed that the individual immune system plays an important role in the fight against the novel coronavirus. Additionally, the innate immune system of the host acts as the first line of defense against invading pathogenic viruses. The host innate immune cells can detect and detoxify the evading viruses. Thus, boosting the innate immune response via targeting activator or inhibitory immune check points pathways for enhancing T-cell immune response may potentially help the patients to fight against this deadly virus. The aim of this editorial is to discuss in brief about the pathogenesis of COVID-19, the role of innate immunity and autophagy during viral clearance.
Export Options
About this article
Cite this article as:
Mehata Kumar Abhishesh*, Dehari Deepa , Mehta Kumar Anuj and Miya Alim , Boosting Innate Immunity During SARS-CoV-2 Clearance, Coronaviruses 2021; 2 (8) : e260721189347 . https://dx.doi.org/10.2174/2666796701999201222113659
DOI https://dx.doi.org/10.2174/2666796701999201222113659 |
Print ISSN 2666-7967 |
Publisher Name Bentham Science Publisher |
Online ISSN 2666-7975 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Discovery of MAO-B Inhibitors - Present Status and Future Directions Part I: Oxygen Heterocycles and Analogs
Mini-Reviews in Medicinal Chemistry Subject Index to Volume 4
Current Topics in Medicinal Chemistry subject Index To Volume 5
Combinatorial Chemistry & High Throughput Screening Recent Approaches to Novel Antibacterials Designed After LPS Structure and Biochemistry
Current Drug Targets COVID-19 and Inflammatory Markers
Current Vascular Pharmacology In Vitro Data of Current Therapies for SARS-CoV-2
Current Medicinal Chemistry Prospects of Antiviral Drugs Derived from Natural Products: Targeting SARS-CoV Entry and Replication
Current Traditional Medicine Synthesis, Characterization and Microbial Activity of New Bisphenol-C Derivatives
Letters in Drug Design & Discovery Statin Intolerance: Why and What to do – With a Focus on Diabetic People
Current Medicinal Chemistry Graphical Abstracts
Current Organic Chemistry Discovery of Anti-Alzheimer Agents: Current Ligand-Based Approaches toward the Design of Acetylcholinesterase Inhibitors
Mini-Reviews in Medicinal Chemistry Nanomedicine: Magnetic Nanoparticles and their Biomedical Applications
Current Medicinal Chemistry Potential of Nanotechnology-based Formulations in Combating Pulmonary Infectious Diseases: A Current Scenario
Current Pharmaceutical Design Are Hsp90 Inhibitors Good Candidates Against Covid-19?
Current Protein & Peptide Science Genetic Polymorphism and Tumor Immunotherapy
Current Pharmacogenomics Inverse Electron Demand Diels-Alder (IEDDA) Reactions: Synthesis of Heterocycles and Natural Products Along with Bioorthogonal and Material Sciences Applications
Current Organic Chemistry New Hybrid Scaffolds based on Hydrazinyl Thiazole Substituted Coumarin; As Novel Leads of Dual Potential; In Vitro α-Amylase Inhibitory and Antioxidant (DPPH and ABTS Radical Scavenging) Activities
Medicinal Chemistry Novel N-mustard-benzimidazoles/benzothiazoles Hybrids, Synthesis and Anticancer Evaluation
Anti-Cancer Agents in Medicinal Chemistry High-throughput Screening Identifies Small Molecule Inhibitors of Molecular Chaperones
Current Pharmaceutical Design Can Host Cell Proteins Like ACE2, ADAM17, TMPRSS2, Androgen Receptor be the Efficient Targets in SARS-CoV-2 Infection?
Current Drug Targets